Emrelis, an antibody drug conjugate developed by AbbVie, is now FDA approved for patients whose non-small cell lung cancer overexpresses the protein c-Met. The pharma company said this ADC is its first internally developed solid tumor medicine as well as its first solid tumor FDA approval in lung cancer. The post AbbVie’s Solid Tumor Strategy…
Covered California, the state’s health insurance marketplace, has hit a record 1.8 million enrollees and the number could climb higher ahead of a Jan. 31 open enrollment deadline, due in large part to enhanced subsidies that have made plans more affordable. But the state’s progress in extending health coverage to all residents could come to…
Former president Donald Trump and Vice President Kamala Harris are both eager to take on high drug prices, leaving pharmaceutical companies on the defensive as they spend millions of dollars this election season. When Harris was California’s attorney general, she joined cases that resulted in almost $7.2 billion (about $22 per person in the United…
By KELLI DEETER I was intrigued by Daniel Stone’s piece on THCB in May titled “Biden’s cancer diagnosis as a teaching moment”. In my practice as a board-certified nurse practitioner, I am frequently asked about prostate specific antigen (PSA) testing by my male patients. Nursing practice and medical practice often get blurred or lumped together….
By MIKE MAGEE The date was June 9, 1954. This was over a year after Wisconsin Republican Senator Joseph R. McCarthy had assumed the chairmanship of the Senate Permanent Subcommittee on Investigations. The history shows that he had “rocketed to public attention in 1950 with his allegations that hundreds of Communists had infiltrated the State Department…
SACRAMENTO, Calif. — For weeks, Mehmet Oz has been waging a public feud with California leaders over health care fraud, accusing the blue state of failing to adequately combat such abuse. Oz, who heads the U.S. Centers for Medicare & Medicaid Services, alleged that there was approximately $3.5 billion of fraud in the hospice and…
ZEM Life is developing a smartwatch that can deliver Narcan to combat a fentanyl overdose. The post How One Company Aims to Save Lives with Its Smartwatch appeared first on MedCity News.
Families filed nearly 23,000 federal civil rights complaints against schools in fiscal 2024, the highest number ever. That includes about 8,400 cases involving allegations of discrimination against students with disabilities, who have struggled to recover academically from the pandemic. Under federal law, public schools must provide children with disabilities a “free appropriate public education,” to…
Threat actors continue to refine their strategies, and the financial incentives for cybercrime persist. However, the combination of stronger defenses, regulatory pressure, and industry collaboration is starting to shift the balance in favor of defenders. The post The Changing Landscape of Ransomware: Why Healthcare Organizations Are Paying Less appeared first on MedCity News.
Recordati is acquiring Sanofi’s Enjaymo, the only approved drug for the rare blood disorder cold agglutinin disease. Achieving sales milestones could bring the deal’s value to more than $1 billion. The post Sanofi Drug for Rare Blood Disease Is Heading to Recordati for $825M appeared first on MedCity News.